Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Insurance Coverage: Some insurance plans may cover Semaglutide injections
Not all treatments are equal
Note: The above statements have not been evaluated by the Food and Drug Administration
Since tirzepatide has been shown to induce medullary thyroid carcinoma in both in vivo rat models and in vitro studies, it is not recommended for use in patients with a history of medullary thyroid carcinoma or those with multiple endocrine neoplasia type 2 syndrome
US$ 22.92
US$ 28.85
US$ 29.53
US$ 20.45
